PhoreMost, C4X Discovery announce neurodegeneration collaboration
The collaboration will initially accelerate C4X Discovery’s Parkinson’s disease drug discovery pipeline.
Read More
Tag: C4X
- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
